Earnings Call · Q2 FY2022·2022-08-10

Q2 22EPS 0.00%·Rev n/aQ1 22EPS +28.57%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS -33.33%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal Officer

Dr. Carl Hansen — Chief Executive Officer

Andrew Booth — Chief Financial Officer

−5.5%1d on move date−5.1% vs SPY3d+13.6%5d+15.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access